The article discusses postherpetic neuralgia, which is described as a continued dermatomal pain after cutaneous healing of zoster. Its ICD-9 code is 0.53.19 herpes zoster with other nervous system complications. Risk factors include old age and more severe initial pain. Its incidence, clinical ...
Postherpetic neuralgia Pain Thalamus Periaqueductal gray matter (PAG) Magnetic resonance imaging (MRI) Anxiety Depression 1. Introduction Postherpetic neuralgia (PHN) is a typical neuropathic pain, which develops after the resolution of the herpes zoster mucocutaneous eruption (Peng et al., 2017). PHN...
3. Kost RG, Straus SE, Postherpetic neuralgia – pathogenesis, treatment, and prevention: N Engl J Med, 1996; 335(1); 32-42 4. Yang F, Yu S, Fan B, The epidemiology of herpes zoster and postherpetic neuralgia in China: Results from a cross-sectional study: Pain Ther, 2019; 8(2);...
Objectives Postherpetic neuralgia (PHN) is a painful, chronic condition. Gabapentin and pregabalin are common first-line medications for PHN and must be titrated over time to effective doses. Individuals with PHN may augment therapy with opioids to control pai n. Pain management for PHN can ...
Gabapentin and pregabalin are recommended as first-line treatments for postherpetic neuralgia (PHN). They are usually taken two or three times per day and must be titrated to an effective dosage over several weeks. For patients who have insufficient pain relief or poor tolerability, opioid ...